Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Business · page 2
- M&A Activity
Organigram – Sanity Group Deal: What Changed and What it Means for Germany
This article was originally published in February 2026, and was most recently updated on September 22, 2026.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
- Cultivation
Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
- CBD Market
French Trade Groups Prepare For Key CBD Ruling
Despite the Council of State knocking back its initial attempt to derail the French authorities’ latest crackdown on CBD, the head of the trade groups fighting the ban remain upbeat on its chances of success.
- Cultivation
The Science of the Cannabis Post-Harvest Process
James Duckenfield, CEO of Glass Pharms®, explains the company’s post-harvest process, including drying and curing, and why freeze-drying is never part of it.
- M&A Activity
Aurora Accuses Curaleaf of ‘Pressuring Shareholders’ as it Launches Official Takeover Bid
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival.
- M&A Activity
Curaleaf’s Aurora Bid Is a Fight for Europe’s Cannabis Crown
Curaleaf Holdings (CURA) announced this week that it intends to launch an unsolicited take-over bid of its rival Aurora Cannabis (ACB) in what would mark one of the most consequential consolidation moves in industry history.
- Business
Data is Becoming Cannabis’ Most Valuable Crop
For more than a decade now, the world’s largest retail conglomerates have been quietly building their consumer data empires.
- Opinion
Selling US Grown Flower to Europe: What the Margin Actually Says
Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the wrong number.
- International Regulation
Isreal Reopens Canadian Cannabis Dumping Case, This Time With a Route Around Its Finance Minister
Israel’s Ministry of Economy and Industry has already reopened its anti-dumping investigation into Canadian medical cannabis, just a week after a procedural defect forced the same case to close.
- Cultivation
Rua Bioscience Signs its Largest-Ever Export Deal With Unnamed UK Cannabis Clinic
New Zealand-listed Rua Bioscience (NZX: RUA) has agreed a sales and distribution deal with one of the UK’s largest medicinal cannabis clinic and distribution businesses, expected to generate NZ$10m in revenue over two years, the company’s largest export contract to date.
